Shandong Cynda Chemical Co.,Ltd. (SHA:603086)
China · Delayed Price · Currency is CNY 8.22
+0.04 (0.49%)
Feb 6, 2026, 3:00 PM CST
Shandong Cynda Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,528 | 2,412 | 2,435 | 3,102 | 2,179 | 1,880 |
Other Revenue | 7.04 | 7.04 | 25 | 24.25 | 23.67 | 15.29 |
| 2,535 | 2,419 | 2,460 | 3,126 | 2,203 | 1,896 | |
Revenue Growth (YoY) | 10.76% | -1.68% | -21.29% | 41.92% | 16.19% | 20.39% |
Cost of Revenue | 2,035 | 2,135 | 2,213 | 2,302 | 1,721 | 1,383 |
Gross Profit | 499.68 | 284.41 | 247.15 | 824.04 | 481.62 | 512.32 |
Selling, General & Admin | 223.06 | 222.04 | 263.17 | 252.75 | 189.76 | 186.84 |
Research & Development | 103.12 | 105.61 | 115 | 144.29 | 98.06 | 95.96 |
Other Operating Expenses | 18 | 10.75 | 11.18 | 9.24 | 7.29 | 6.12 |
Operating Expenses | 348.04 | 344.39 | 386.74 | 412.78 | 303.28 | 284.22 |
Operating Income | 151.64 | -59.98 | -139.6 | 411.25 | 178.33 | 228.11 |
Interest Expense | -16.77 | -11.03 | -7.09 | -3.52 | -0.46 | -0.71 |
Interest & Investment Income | 8.58 | 7.31 | 7.89 | 6.24 | 21.7 | 11.56 |
Currency Exchange Gain (Loss) | 12.91 | 12.91 | 7.83 | 52.54 | -8.23 | -22.65 |
Other Non Operating Income (Expenses) | 0.93 | -0.43 | -1.78 | -2.14 | -1.86 | -1.77 |
EBT Excluding Unusual Items | 157.28 | -51.22 | -132.74 | 464.38 | 189.48 | 214.54 |
Gain (Loss) on Sale of Investments | -0.13 | -0.38 | -5.79 | -61.31 | 8.59 | 10.32 |
Gain (Loss) on Sale of Assets | -5.15 | -1.7 | -0.71 | -0.59 | -3.44 | -1.94 |
Asset Writedown | -6.77 | - | - | - | - | -2.9 |
Other Unusual Items | 19.97 | 10.42 | 7.84 | 10.36 | 7.17 | -5.37 |
Pretax Income | 165.19 | -42.87 | -131.41 | 412.84 | 201.8 | 214.65 |
Income Tax Expense | 2.48 | -17.27 | -29.98 | 31.84 | 24.42 | 38.62 |
Earnings From Continuing Operations | 162.71 | -25.6 | -101.44 | 381.01 | 177.38 | 176.03 |
Minority Interest in Earnings | 1.11 | -0.28 | -2.67 | 0.19 | - | - |
Net Income | 163.82 | -25.88 | -104.1 | 381.2 | 177.38 | 176.03 |
Net Income to Common | 163.82 | -25.88 | -104.1 | 381.2 | 177.38 | 176.03 |
Net Income Growth | - | - | - | 114.90% | 0.77% | -13.97% |
Shares Outstanding (Basic) | 293 | 431 | 434 | 433 | 436 | 431 |
Shares Outstanding (Diluted) | 293 | 431 | 434 | 433 | 436 | 431 |
Shares Change (YoY) | -41.85% | -0.58% | 0.13% | -0.58% | 1.04% | -0.14% |
EPS (Basic) | 0.56 | -0.06 | -0.24 | 0.88 | 0.41 | 0.41 |
EPS (Diluted) | 0.56 | -0.06 | -0.24 | 0.88 | 0.41 | 0.41 |
EPS Growth | - | - | - | 116.16% | -0.27% | -13.85% |
Free Cash Flow | -432.14 | -232.17 | -192.62 | 66.58 | 25.85 | 232.19 |
Free Cash Flow Per Share | -1.47 | -0.54 | -0.44 | 0.15 | 0.06 | 0.54 |
Dividend Per Share | - | - | - | 0.179 | 0.128 | 0.128 |
Dividend Growth | - | - | - | 39.97% | - | 63.38% |
Gross Margin | 19.71% | 11.76% | 10.04% | 26.36% | 21.87% | 27.03% |
Operating Margin | 5.98% | -2.48% | -5.67% | 13.16% | 8.10% | 12.03% |
Profit Margin | 6.46% | -1.07% | -4.23% | 12.20% | 8.05% | 9.29% |
Free Cash Flow Margin | -17.05% | -9.60% | -7.83% | 2.13% | 1.17% | 12.25% |
EBITDA | 383.52 | 144.48 | 28.31 | 524.63 | 257.69 | 277.4 |
EBITDA Margin | 15.13% | 5.97% | 1.15% | 16.78% | 11.70% | 14.63% |
D&A For EBITDA | 231.88 | 204.47 | 167.91 | 113.38 | 79.35 | 49.29 |
EBIT | 151.64 | -59.98 | -139.6 | 411.25 | 178.33 | 228.11 |
EBIT Margin | 5.98% | -2.48% | -5.67% | 13.16% | 8.10% | 12.03% |
Effective Tax Rate | 1.50% | - | - | 7.71% | 12.10% | 17.99% |
Revenue as Reported | 2,535 | 2,419 | 2,460 | 3,126 | 2,203 | 1,896 |
Advertising Expenses | - | 7.03 | 6.92 | 8.2 | 5.31 | 2.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.